Evidence map›Paper›PMID 33618730›Full record

ArticleCritical care (London, England)2021

Role of endothelial microRNA 155 on capillary leakage in systemic inflammation.

Valerie Etzrodt, Temitayo O Idowu, Heiko Schenk, Benjamin Seeliger, Antje Prasse, Kristina Thamm, Thorben Pape, Janina Müller-Deile, Matijs van Meurs, Thomas Thum and 6 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Valerie Etzrodt *Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-9493-5346
Temitayo O Idowu *Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Heiko SchenkDivision of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Benjamin SeeligerDepartment of Respiratory Medicine and German Center for Lung Research, Hannover Medical School, Hannover, Germany.
Antje PrasseDepartment of Respiratory Medicine and German Center for Lung Research, Hannover Medical School, Hannover, Germany.
Kristina ThammDivision of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Thorben PapeDivision of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Janina Müller-DeileDivision of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.
Matijs van MeursDepartment of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Ankita GargInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Robert GeffersHelmholtz Centre for Infection Research Brunswick, Brunswick, Germany.
Klaus StahlDivision of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Samir M ParikhCenter for Vascular Biology Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Hermann HallerDivision of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Sascha DavidDivision of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany. david.sascha@mh-hannover.de.
Medizinische Hochschule Hannover · DEMount Desert Island Biological Laboratory · USBeth Israel Deaconess Medical Center · USHelmholtz Centre for Infection Research · DEUniversitätsklinikum Erlangen · DEUniversity Medical Center Groningen · NL

Funding

Deutsche Forschungsgemeinschaft DA 1209/4-3Deutsche Forschungsgemeinschaft ME 3696/3-1
6 · The paper itself

Abstract

backgroundCapillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage.

methodsSmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance.

resultsEndothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects.

conclusionsWe found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.

Indexed as

AnimalsCapillary Leak SyndromeEndothelium, VascularHumansMiceMicroRNAsSystemic Inflammatory Response SyndromeZebrafishMicroRNAsMIRN155 microRNA, humanMirn155 microRNA, mouseEndotheliumMicroRNAsRespiratory distress syndromeSepsisTight junctions

Identifiers

PMID33618730
PMCPMC7901081
OpenAlexW3130605829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.